TRNS · CIK 0000099302
What Transcat, Inc. told the SEC could break it.
Transcat's sharpest exposure is on its supply side: in its distribution business, its top 10 vendors account for about 65% of sales and its single largest roughly 25%, so losing a key product vendor or rebate program would disrupt both supply and economics. Because it resells imported test-and-measurement instruments, it is also exposed to U.S. trade-policy shifts — higher tariffs, sanctions and export restrictions that could raise the cost of the products it distributes — and to FX and FCPA risk from its Canadian, Euro and Costa Rica operations. Layered on that, much of its growth comes through acquisitions (about $131.6 million of calibration-services deals in fiscal 2025), carrying the usual integration, valuation and goodwill-impairment risk.
4 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Supplier concentration
- top-10 vendors ≈65% of distribution sales (largest ~25%)high
Transcat's distribution segment depends on a concentrated vendor base — its top 10 vendors accounted for ~65% of aggregate distribution sales (with the largest ~25%); loss of a key product vendor or rebate program could disrupt its product supply and economics.
“approximately 25% of our aggregate Distribution sales and our top 10 vendors accounted for approximately 65% of our aggregate Distribution sales.”
SEC filing →As of 2026
Geographic concentration
- international operations (Canada/Euro FX, Costa Rica) and FCPA exposuremedium
Although under 10% of revenue is export, Transcat operates internationally (Canadian and Euro-denominated sales, a Costa Rica calibration acquisition) and is exposed to FX fluctuations, foreign trade/exchange restrictions, FCPA/anti-bribery compliance and political instability.
“Our revenue is subject to the customary risks of operating in an international environment, including the potential imposition of trade or foreign exchange restrictions, tariff and other tax increases, fluctuations in exchange rates and unstable political situations, any one or more of which could have a material adverse effect on our business, cash flows, balance sheet or results of operations.”
SEC filing →As of 2026
Other disclosures
- acquisition-driven growth and integration risk (Essco, Martin, SCM Metrology)medium
Transcat's growth strategy relies heavily on acquisitions — it completed multiple calibration-services deals (~$131.6M aggregate in fiscal 2025, plus Essco — its largest deal — and SCM Metrology in Costa Rica) — exposing it to integration, valuation and goodwill-impairment risk.
“during the year ended March 29, 2025, the Company completed multiple business combinations for an aggregate purchase price of approximately $131.6 million.”
SEC filing →As of 2026
Regulatory & policy
- tariffs/trade-policy changes on imported instruments; trade restrictionsmedium
Transcat distributes test-and-measurement instruments and is exposed to U.S. trade-policy changes — higher tariffs, trade-agreement renegotiation/termination, sanctions and export restrictions — that could raise the cost of imported products it resells and disrupt supply.
“the United States has recently instituted or proposed changes in trade policies that include the negotiation or termination of trade agreements, the imposition of higher tariffs on imports into the United States, economic sanct”
SEC filing →As of 2026
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch